Supplement: Mark Tykocinski

Mark Tykocinski By Karen Pallarito Open doors lead a scientist to his calling. RELATED ARTICLES Successful Strategies Margaret Foti: Devoted to cancer research The Launch and the Exit Entrepreneurs Boldly Break New Ground Shire Pharmaceuticals: A Study in Exponential Growth Many Happy Returns: Cephalon celebrates its 20th year Creative Collaboration DUSTIN FENSTERMACHER / WONDERFUL MACHINE In the summer of 1971, Yale undergraduate Mar

Written byKaren Pallarito
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Successful Strategies

Margaret Foti: Devoted to cancer research

The Launch and the Exit

Entrepreneurs Boldly Break New Ground

Shire Pharmaceuticals: A Study in Exponential Growth

Many Happy Returns: Cephalon celebrates its 20th year

Creative Collaboration

In the summer of 1971, Yale undergraduate Mark Tykocinski, who was studying philosophy at the time, wandered into a building on the campus of Boston's Harvard School of Public Health and stumbled upon the lab of famed cardiologist Bernard Lown. The door was open, so he walked in, introduced himself, and asked to work in the lab. That chance meeting with Lown, developer of the cardiac defibrillator, led to three consecutive summers working on special projects that gave the young protégé his first scientific publication as a student.

Working for Lown sealed his destiny, says Tykocinski, while "a very fateful dinner" at his sister's apartment put his career path in perspective. "Mark," she asked, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies